Carvolix Liquidity Contract Review for the First Half of 2026

On July 8, 2026, Affluent Medical published the half-year report on the Carvolix liquidity contract. Managed by Rothschild Martin Maurel, the liquidity account as of June 30, 2026, held 1,391 shares and €234,326. Between January and June 2026, 1,878 purchases were made, totaling 106,012 shares for €337,294.46. Concurrently, 1,630 sales took place, representing 112,525 shares for €344,721.56.

Compared to the end of 2025, when the account held 11,800 shares and €208,448, a significant decrease in the number of shares is observed. Following a reorganization, Rothschild & Co Global Markets Solutions now manages the contract, without altering the established terms.